Robotic Surgery at CMJ Hospital
Hospital Updates

SOUTH MUMBAI BASED 60+ YEAR OLD CMJ JAIN Hospital introduces IN A FIRST AS A CHARITABLE HOSPITAL, robotic surgery on SSI Mantra platform

CMJ Hospital, a beacon of healthcare for the poor & needy in Girgaon, Mumbai, with a legacy spanning 60+ years, has announced a groundbreaking advancement in surgical care with the introduction of robotic surgery on the SSI Mantra platform. This initiative is aligned with CMJ Hospital’s commitment to providing world-class treatment to the community, particularly […]

"Antimicrobial Blue Light Technology"
Digital Health News

IlluminOss Subsidiary ABL Medical Developing Anti-Microbial Blue Light Fiber Technology!

ABL Medical Inc. a subsidiary of IlluminOss Medical Inc. In 2018, IlluminOss Medical began offering a system in the US that used blue light delivered via a long fiber-optic catheter to harden light-curing liquid within balloon-like orthopedic implants. Now, data from ABL Medical demonstrates that blue light with fiber-optic technology may be adapted for antimicrobial […]

"revyve Antimicrobial Wound Gel Spray Demonstration"
Digital Health News

Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray

Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel, and will be introducing it today at the Boswick Burn and Wound Care Symposium. “Kane has taken […]

Yashoda Hospitals - Oral Cancer Treatment Success
Hospital Updates


Yashoda Hospitals (Malakpet) Hyderabad, a leading healthcare institution, has successfully treated  an elderly man aged 57 from Warrangal suffering from CA. Buccal Mucosa, commonly known as oral cancer. The patient was first admitted under Dr. Hari Krishna Reddy. K, Consultant General & Laparoscopic Surgeon, Yashoda Hospitals Hyderabad, who then referred it to Dr. Shaik Saleem, […]

Inspira ART100 Collaboration - Northwestern Memorial Hospital
Hospital Updates

Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device

Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent (LOI) with Northwestern Memorial Hospital in Chicago, Illinois (“Northwestern”). Northwestern, ranked as the eighth best hospital in the United States by Newsweek in 2023, is part of […]

Drug Updates

Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has completed enrollment in its pivotal Phase 3 clinical trial for Mino-Lok®, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections. A total of […]

OcuLenz AR/XR Headset for Macular Degeneration Patients
Device Digest

Ocutrx Unveils OcuLenz AR/XR Headset, Aiding Vision for Patients with Advanced Macular Degeneration

Ocutrx Technologies, Inc., a leader in augmented reality (AR) and 3D technology for medical and surgical applications, today is pulling back the curtain on its latest innovation: OcuLenz™, its groundbreaking AR/XR headset. OcuLenz is engineered to enhance visual clarity for individuals living with advanced macular degeneration (AMD). This innovative AR/XR headset is designed to be lightweight […]

Dr. William T. Lowrance, Chief Medical Officer at Vesica Health
Hospital Updates

Vesica Health Appoints Distinguished Urologic Oncologist Dr. William T. Lowrance to Chief Medical Officer

VESICA HEALTH, INC., a multi-omics, liquid biopsy company transforming the management of hematuria patients and improving the early detection of bladder cancer, today announced that William T. Lowrance, MD, MPH, MBA will serve as the company’s Chief Medical Officer. Dr. Lowrance brings more than 20 years of clinical experience, as a professor of urology and a […]

TAR-210 Phase 1 Study Results
Drug Updates

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from an open-label, multicenter Phase 1 study evaluating the safety and efficacy of TAR-210, an intravesical delivery system designed to provide sustained, local release of erdafitinib into the bladder in patients with non-muscle-invasive bladder cancer (NMIBC) with select fibroblast growth factor receptor (FGFR) […]

LUMAKRAS and Vectibix Phase 3 Trial Results
Drug Updates


Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses of LUMAKRAS® (sotorasib) (960 mg or 240 mg) in combination with Vectibix® (panitumumab). Both doses demonstrated a statistically significant superiority in progression-free survival (PFS) over the investigator’s choice of therapy in patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). The results are being presented today […]